One in five privately insured Americans were denied coverage for doctor-recommended care last year, and for a sizable share the fallout was fresh medical debt, according to a Commonwealth Fund survey released yesterday.
Nearly 70% of patients who had a claim denied said it cost their household more money, and 43% said the denial left them with medical debt they are still paying off. More than half of those affected said the original denied bill ran $1,000 or more.
The report also surfaced a direct collections dynamic. In focus groups, some patients said their providers threatened to send overdue balances to collections while their insurance appeals were still pending, leaving them worried that prolonged disputes would damage their credit. Others said they simply paid the contested bill to avoid the risk, and some began avoiding care altogether.
Appeals were inconsistent and slow. Only about half of denied patients challenged the decision, with many unsure they had the right to appeal or doubtful it would matter. Among those who appealed a prior authorization denial, more than half eventually won some form of coverage, either for the original care (30%) or an alternative (25%). One-third of patients who contested a claim denial had their bills reduced or wiped out. Many waited two weeks or longer for a ruling.
The findings carry weight for an industry where medical debt remains a contested asset class. The Commonwealth Fund used the data to press for standardized, more transparent denial and appeal rules across all private plans, citing a patchwork of regulations that has not kept pace with the market. Its policy menu includes broader appeal rights, restored federal funding for consumer assistance programs, expanded public reporting on denials, and plain-language explanations of coverage decisions.
“We need greater transparency, expansion of appeal rights, and standardization of utilization review processes across all insurance plans to help patients have confidence in their insurance,” said Sara Collins, a Commonwealth Fund senior scholar and report co-author, in a statement.
